The effect of beraprost sodium on the Raynaud’s phenomenon

Japanese Journal of Clinical Immunology

Volumn 19, Issue 3, 1996, Pages 193-200

  Hiida, Megumi ^a,b   Ushiyama, Osamu ^a,b   Suzuki, Noriaki ^a,b   Ohta, Akihide ^a   Nagasawa, Kohei ^a,b   Yamaguchi, Masaya ^a,c  

^a SAGA UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Beraprost; Endothelial damage; Prostaglandin; Raynaud S phenomenon; Systemic sclerosis

Indexed keywords

BERAPROST; BIOLOGICAL MARKER; DRUG DERIVATIVE; ENDOTHELIN; PROSTACYCLIN; TISSUE PLASMINOGEN ACTIVATOR; VASODILATOR AGENT; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; FINGER; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RAYNAUD PHENOMENON; SKIN TEMPERATURE; VASCULARIZATION;

ADULT; AGED; BIOLOGICAL MARKERS; ENDOTHELINS; EPOPROSTENOL; FEMALE; FINGERS; HUMANS; MALE; MIDDLE AGED; RAYNAUD DISEASE; SKIN TEMPERATURE; TISSUE PLASMINOGEN ACTIVATOR; VASODILATOR AGENTS; VON WILLEBRAND FACTOR;

EID: 0030157702     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.19.193     Document Type: Article

References (7)

1. Marasini, B., Cugno, M., Bassani, C., Stanzani, M., Bottasso, B., Agostoni, A.: Tissue-type plasminogen activator and von Wille-brand factor plasma levels as markers of endothelial involvement in patients with Raynaud’s phenomenon. Int. J. Microcirc.: Clin. Exp., 11: 375–382, 1992.
2. Maricq, H.R., LeRoy, E.C.: Patterns of finger capillary abnormalities in connective tissue disease by ‘wide-field’ microscopy. Arthritis Rheum., 16: 619–628, 1973.
3. Climminiello, C., Arpaia, G., Toschi, V., Rossi, F., Aloisio, M., Motta, A., Bonfardeci, G.: Plasma levels of tumor necrosis factor and endothelial response in patients with chronic arterial obstructive disease or Raynayd’s phenomenon. Angiol., 45: 1015–1022, 1994.
4. M., Yanagisawa, H., Kurihara, S., Kimura, Y., Tamobe, M., Kobayashi, Y., Mitsui, Y., Yazaki, K., Goto, T., Masaki, Endothelin: A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, (1988), 332, 411-415
5. Kahaleh, M.B.: Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum., 34: 978–983, 1991.
6. Yamane, K., Kashiwagi, H., Suzuki, N., Miyauchi, T., Yanagisawa, M., Goto, K. and Masaki, T.: Elevated plasma leveles of endothelin-1 in systemic sclerosis [letter]. Arthritis Rheum., 34: 243–244, 1991.
7. Herrick A.L., Illingworth K., Blann A., Hay C.R.M., Hollis S., Jayson M.I.V.: Von Wille-brand factor, thrombomodulin, thromboxane, β - thromboglobulin and markers of fibrinolysis in primary Raynaud’s phenomenon and systemic sclerosis. Ann Rheum Dis., 55: 122–127, 1996.